The single highest-leverage piece of intelligence a home care seller can have heading into a process is which private equity firms are likely to pay the most for their specific business. Buyer-type matching — by sub-sector, geography, EBITDA size, payer mix, and growth profile — is the difference between a competitive process clearing at the top of the multiple range and a one-buyer conversation clearing at the bottom.
Below are profiles of the private equity firms most actively buying in home-based care in 2026: their active platforms, sweet-spot agency size, sub-sector focus, and what they typically want in a seller.
Note: PE firm activity changes quarterly. The profiles below reflect Hendon Partners’ direct dialogue with each firm and tracked deal activity through Q2 2026. We update our internal database continuously and tailor each engagement to the most current buyer landscape.
How to Use This Guide
PE firms vary along three axes that matter for sellers:
- Check size and stage — platform vs. tuck-in, equity check ranges, fund size
- Sub-sector focus — personal care, home health, hospice, IDD, ABA/autism, behavioral health, pediatric
- Investment philosophy — buy-and-build (highly acquisitive), organic-growth-focused, operator-led, financial engineering
The right buyer for an agency is the firm whose active mandate matches the agency’s profile today. Wrong-fit outreach destroys time and tips off the market without producing bids.
Tier 1: Most Active Home-Based Care PE Buyers in 2026
Alpine Investors
- HQ: San Francisco
- Fund size (current): $4.5B+ (Fund IX)
- Home care platforms: Multiple in personal care and home health
- Sweet spot: $3M–$15M EBITDA platforms; tuck-ins of any size
- Sub-sector focus: Personal care, home health, hospice
- Investment thesis: People-first buy-and-build. Heavy emphasis on developing CEOs from within, operator-led growth, and culture preservation.
- What they want from sellers: Founder willing to engage in transition; clean books; growth runway; equity rollover preferred
- Notable for sellers: Among the most disciplined cultural diligence in the market. Sellers who care about post-close legacy often align well.
Blue Wolf Capital
- HQ: New York
- Fund size: $1.5B+ recent fund
- Home care platforms: Active in hospice and home health consolidation
- Sweet spot: $5M–$25M EBITDA platforms; tuck-ins to portfolio
- Sub-sector focus: Hospice, home health, multi-service home-based care
- Investment thesis: Healthcare services consolidation with operational improvement focus
- What they want from sellers: Strong management depth; clean compliance; willingness to be part of platform vision
- Notable for sellers: Highly active in hospice; experienced in CHOW execution across multiple states
Kinderhook Industries
- HQ: New York
- Fund size: $2.5B+ recent fund
- Home care platforms: Multiple home-based care holdings; Enhabit-related transaction context
- Sweet spot: Large platforms ($10M+ EBITDA); selective on tuck-ins
- Sub-sector focus: Healthcare services, home-based care
- Investment thesis: Buy-and-build with a focus on multi-site healthcare services
- What they want from sellers: Scaled platforms with management depth; significant rollover often expected
- Notable for sellers: Capable of executing very large transactions; appropriate for sellers at platform scale
The Vistria Group
- HQ: Chicago
- Fund size: $3B+ recent fund
- Home care platforms: Strong activity in behavioral health, IDD, and adjacent home-based care
- Sweet spot: $5M–$20M EBITDA platforms
- Sub-sector focus: Behavioral health, IDD, ABA/autism therapy, healthcare services
- Investment thesis: Mission-aligned healthcare investment with policy-aware approach
- What they want from sellers: Strong outcomes and quality measures; alignment on social impact; growth runway
- Notable for sellers: Particularly attractive for behavioral health and IDD sellers who care about mission continuity
Webster Equity Partners
- HQ: Waltham, MA
- Fund size: $1.5B+
- Home care platforms: Active in hospice and home health
- Sweet spot: $3M–$15M EBITDA platforms; active tuck-in program
- Sub-sector focus: Hospice, home health, healthcare services
- Investment thesis: Buy-and-build in regulated healthcare services; founder-friendly structures
- What they want from sellers: Quality-focused operators; willingness to participate in roll-up
- Notable for sellers: Reputation for fair seller treatment; experienced in healthcare regulatory complexity
Audax Group
- HQ: Boston
- Fund size: $5B+ Audax Private Equity Fund VII
- Home care platforms: Multiple home-based care platforms
- Sweet spot: $5M–$30M EBITDA platforms; large tuck-in programs
- Sub-sector focus: Multi-sector — personal care, home health, hospice, behavioral health
- Investment thesis: Highly disciplined buy-and-build with heavy add-on volume
- What they want from sellers: Operating excellence; integration-ready operations; clean diligence
- Notable for sellers: Among the most prolific add-on acquirers in healthcare services
Tier 2: Highly Active Sub-Sector Specialists
Linden Capital Partners
- HQ: Chicago
- Focus: Healthcare and life sciences only
- Sub-sector activity: Behavioral health, healthcare services, home-based care
- Sweet spot: $5M–$25M EBITDA platforms
- What they want: Healthcare-only firm with deep regulatory understanding; appropriate for complex regulatory situations
Charlesbank Capital Partners
- HQ: Boston
- Focus: Middle market across multiple sectors
- Sub-sector activity: Behavioral health, ABA, healthcare services
- Sweet spot: $10M+ EBITDA platforms
- What they want: Scaled operators with platform potential
Nautic Partners
- HQ: Providence
- Focus: Middle market healthcare services
- Sub-sector activity: Home-based care, behavioral health, healthcare services
- Sweet spot: $5M–$20M EBITDA
- What they want: Operator-led platforms; founder transitions
General Atlantic
- HQ: New York
- Focus: Growth equity, larger transactions
- Notable transaction: TEAM Services-related activity
- Sweet spot: Large platforms ($20M+ EBITDA)
- What they want: Established platforms with national scale potential; appropriate for upper-middle-market sellers
Centerbridge Partners
- HQ: New York
- Focus: Diversified — opportunistic in healthcare
- Sweet spot: Large platforms
- What they want: Scale and complexity
Genstar Capital
- HQ: San Francisco
- Focus: Middle market across multiple sectors
- Sub-sector activity: Healthcare services, business services
- Sweet spot: $10M+ EBITDA
- What they want: Buy-and-build platforms with established management
The mid-market and lower-middle-market home care segment is increasingly active with independent sponsors, family offices, and emerging PE firms. These buyers are often the right fit for first-time sellers in the $1M–$5M EBITDA range where Tier 1 funds prefer tuck-ins to existing platforms.
Categories include:
- Healthcare-focused independent sponsors — typically backed by family offices, often founder-friendly
- Family offices direct-investing in home care — long hold horizons, often less rollover pressure
- Search funds led by healthcare operators — single-asset acquirers, founder-friendly
A specialized advisor curates this set carefully — it changes constantly and not all sponsors close at announced terms.
Strategic Acquirers Sellers Should Also Know
While this guide focuses on PE, strategic acquirers continue to drive a meaningful share of mid-market home care M&A. The most active in 2026 include:
- Help at Home (PE-backed, Centerbridge & Vistria) — personal care consolidation
- Addus HomeCare (NASDAQ: ADUS) — multi-service home-based care
- BrightSpring Health Services (NASDAQ: BTSG) — home care, pharmacy, behavioral health
- Aveanna Healthcare (NASDAQ: AVAH) — pediatric and adult home health
- Pennant Group (NASDAQ: PNTG) — hospice and home health
- Enhabit (NYSE: EHAB) — Medicare home health
- Optum / UnitedHealth Group — Medicare home health (Amedisys-pending)
- HCSG, Senior Helpers, BrightStar — selective franchise and corporate-led acquisitions
Strategic buyers value differently than PE — typically with a synergy lens that can produce higher net multiples for the right asset.
How to Match Your Agency to the Right Buyer
Five variables drive buyer-fit in home care M&A:
1. Service Line
- Personal care: Alpine, Help at Home, Addus, BrightSpring, Audax portfolio
- Medicare home health: Webster, Blue Wolf, Pennant, Enhabit, Optum
- Hospice: Webster, Blue Wolf, Pennant, BrightSpring portfolio
- IDD: Vistria, BrightSpring, Linden
- ABA / Autism therapy: Vistria, Charlesbank, Linden, Audax portfolio
- Behavioral health: Vistria, Charlesbank, Linden
- Pediatric home health: Aveanna, Vistria, BAYADA-affiliated buyers
2. EBITDA Size
- <$1M: Independent sponsors, smaller strategics, single-buyer tuck-ins
- $1M–$3M: Tier 1 PE platform tuck-ins, smaller strategic add-ons
- $3M–$10M: Tier 1 and Tier 2 PE add-ons; platform launches in some sub-sectors
- $10M+: New platform launches; mega-fund interest
3. Geography
- CON states: Limited buyer set — premium pricing for transferable certificates
- Sunbelt growth markets: Broadest buyer interest
- Mature Northeast / Midwest: Strategic and PE consolidator focus
4. Payer Mix
- Medicare-heavy: Different buyer pool than Medicaid-heavy
- MLTSS / managed Medicaid: Increasingly favored by PE
- Private pay-heavy: Highest valuations historically; specific buyer set
5. Owner Post-Close Intentions
- Full exit, fast: Strategics and select PE
- Rollover and stay: PE platforms (most prefer this structure)
- Partial liquidity, continue running: PE majority recapitalization
What Sellers Get Wrong About PE Buyers
Mistake #1: Approaching one firm directly.
Single-firm conversations forfeit the leverage that drives valuation. The right move is a curated, competitive process across 8–15 well-matched firms.
Mistake #2: Assuming the biggest fund pays the most.
The biggest fund is often the worst fit for a $2M EBITDA agency. Right-sized PE pays the best price.
Mistake #3: Believing the headline multiple.
PE multiples come with structure: rollover, earnout, working capital pegs, escrow. The seller’s net cash at close is what matters — and that requires structural negotiation.
Mistake #4: Not vetting closing track record.
Some PE firms have higher pull rates between LOI and close than others. Recent closing track record is a critical buyer-quality signal.
Mistake #5: Underestimating the post-close relationship.
Rollover means you are partners with this PE firm for 3–7 years. Cultural fit during diligence is not a soft factor — it is a financial one.
How Hendon Partners Matches Sellers to PE Buyers
For each engagement, Hendon Partners curates the buyer list to the subset of PE firms most likely to pay a premium for that specific combination of service line, geography, EBITDA size, payer mix, and seller goals.
We maintain active dialogue with 200+ qualified buyers across home-based care — including every firm profiled above and dozens more not listed publicly. Our role is to convert that intelligence into competitive process design that drives the best price and structure for the seller.
Schedule a confidential conversation with Hendon Partners about which PE firms are right for your agency →
Hendon Partners is a sell-side only home care M&A advisory firm. We do not represent buyers. The buyer profiles above reflect our direct market engagement and tracked transaction activity through Q2 2026.
